Tomasz M. Beer, M.D., F.A.C.P.

  • Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
  • Grover C. Bagby Chair of Prostate Cancer Research
  • OHSU Knight Cancer Institute Deputy Director, OHSU Knight Cancer Institute, School of Medicine
  • Chief Medical Officer, CEDAR, OHSU Knight Cancer Institute, School of Medicine
  • Cancer Biology Graduate Program, School of Medicine


Dr. Beer’s major research interests include clinical trials, preclinical investigation and risk factors in prostate cancer. His program investigates a broad range of novel agents for prostate cancer, including immune therapies, nutritional supplements, hormonal agents, chemotherapy drugs and target biologic drugs that seek to exploit prostate cancer’s unique vulnerabilities.

Dr. Beer’s clinical research program is tightly linked with laboratory investigations designed to reveal new treatment targets and strategies.


  • M.D., 1991, The Johns Hopkins University
  • Residency:

    • Oregon Health & Science University, Portland
  • Fellowship:

    • Hematology and Medical oncology, Oregon Health & Science University, Portland
  • Certifications:

    • Oncology

Memberships and associations

  • American College of Physicians
  • Oregon Medical Association
  • American Society of Clinical Oncology
  • American Association for Cancer Research
  • Southwest Oncology Group
  • American Urological Association



  • {{ pub.journalAssociation.journal.names[0].value }}